Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 1

Research Article

A Randomized Double-Blind Placebo-Controlled Trial to Evaluate Prophylactic Effect of Traditional Chinese Medicine Supplementing Qi and Hemostasis Formula on Gastrointestinal Bleeding after Percutaneous Coronary Intervention in Patients at High Risks

Table 1

Baseline patient demographics.

Treatment (N=59)Control (N=58)StatisticP value

Age0.16(Z)0.8699
Gender0.10(X2)0.7518
 Male N(%)22(37.29)20(34.48)
 Female N(%)37(62.71)38(65.52)
Weight (kg)0.33(Z)0.7451
Height (m)-0.66(Z)0.5083
SBP (mmHg)0.54(Z)0.5911
HR (beat/min)2.45(Z)0.0141

SBP indicates systolic blood pressure; HR indicates heart rate.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.